Zentek (ZTEK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ZTEK Zentek

Watchlist

1.140
-0.048-4.04%

Trading Nov 21 14:10 ET

118.63MMarket Cap-15833P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Zentek Second Quarter 2025 Earnings: CA$0.03 Loss per Share (Vs CA$0.034 Loss in 2Q 2024)
Yahoo FinanceNov 16 08:06 ET
Zentek Reports Decreased Assets and Comprehensive Loss
TipRanksNov 14 06:29 ET
Zentek Ltd: INTERIM MDA EN
SEDARNov 13 20:08 ET · Announcements
Zentek Ltd: INTERIM FINANCIAL STATEMENTSREPORT EN
SEDARNov 13 20:06 ET · Announcements
Zentek's Triera Unit Wins $1.1 Million Bird Flue Vaccine Development Contract From Canadian Government
MT NewswiresNov 6 11:03 ET
Zentek Secures Canadian Contract for Drug Discovery
TipRanksNov 6 07:43 ET

Comments

Stock_Drift

Nov 15 13:26

Unusual Volume Ticks. 2:25pm

$Fundamental Global (FGF.US)$ $Cineverse (CNVS.US)$ $Zentek (ZTEK.US)$ $Compass Minerals (CMP.US)$ $Solidion Technology (STI.US)$ $Pulmatrix (PULM.US)$ $PTL Ltd (PTLE.US)$ $QT Imaging (QTI.US)$ $Simpple (SPPL.US)$ $Cyclerion Therapeutics (CYCN.US)$ $Bloom Energy (BE.US)$ $CERo Therapeutics (CERO.US)$ $The Arena Group (AREN.US)$
📊⚡️📊

Jaguar8

Oct 17 07:11

NEWS

$Zentek (ZTEK.US)$
Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks
Zentek (NASDAQ:ZTEK)(TSXV:ZEN) has provided an update on the commercialization of its ZenGUARD™ Antimicrobial Surgical Masks. Following a Canada-wide sampling program for dental professionals through Henry Schein Inc., the company is experiencing increased demand for its product. Zentek is exploring opportunities in the beauty space and international healthcare markets. The company has applied to the...

Jaguar8

May 6 06:23

$Zentek (ZTEK.US)$
NEWS
Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology
Zentek announces that its subsidiary, Triera Biosciences , has achieved positive results against avian influenza (H5N1) using multivalent aptamer technology. The development of a prophylaxis and therapeutic for highly pathogenic avian influenza has been prioritized, with promising initial test results. The binding affinity of the influenza aptamer...